Jiangsu Bide Science And Technology Co.Ltd(605298) issue annual report. In 2021, the company realized an operating income of Zhejiang Tianyu Pharmaceutical Co.Ltd(300702) 37074 yuan, a decrease of 13.47% over the same period of last year, and the net profit attributable to the shareholders of the parent company was 8452608204 yuan, a decrease of 19.11% over the same period of last year. The company plans to distribute cash dividends of 4 yuan (including tax) for every 10 shares and increase 3 shares for every 10 shares.